BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11783335)

  • 21. [Hepatolenticular degeneration. Present status of chemical pathology and treatment. I. Normal metabolism of copper and disorder of copper metabolism in hepatolenticular degeneration].
    BOUDIN G; PEPIN B
    Presse Med (1893); 1962 Apr; 70():1027-30. PubMed ID: 13871780
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative study on therapeutic effects of gandou tablet I and dimercaptosuccinate acid in treating Wilson disease].
    Han Y; He G; Wang X
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Feb; 19(2):69-70. PubMed ID: 11783297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper.
    Lindquist RR
    Arch Pathol; 1969 Apr; 87(4):370-9. PubMed ID: 5766764
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatocerebral degeneration. Its occurrence in the presence and in the absence of abnormal copper metabolism.
    Popoff N; Budzilovich G; Goodgold A; Feigin I
    Neurology; 1965 Oct; 15(10):919-30. PubMed ID: 5890884
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contrast analysis of brainstem auditory evoked potential in untreated and treated hepatolenticular degeneration patients with treatment of combining traditional Chinese and Western medicine].
    Xu SH; Cai YL; Yang RM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Jan; 17(1):17-9. PubMed ID: 9812644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I
    Prog Liver Dis; 1972; 4():511-25. PubMed ID: 4569009
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of drugs upon the copper metabolism in hepatolenticular degeneration and in normal subjects.
    ZIMDAHL WT; HYMAN I; STAFFORD WF
    J Lab Clin Med; 1954 May; 43(5):774-84. PubMed ID: 13163577
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on copper metabolism. XIII. Hepatolenticular degeneration.
    CARTWRIGHT GE; HODGES RE; GUBLER CJ; MAHONEY JP; DAUM K; WINTROBE MM; BEAN WB
    J Clin Invest; 1954 Nov; 33(11):1487-501. PubMed ID: 13211803
    [No Abstract]   [Full Text] [Related]  

  • 29. The intrahepatic distribution of copper in relation to the pathogenesis of hepatolenticular degeneration.
    UZMAN LL
    AMA Arch Pathol; 1957 Oct; 64(4):464-79. PubMed ID: 13457604
    [No Abstract]   [Full Text] [Related]  

  • 30. Copper storage in hepatolenticular degeneration and allied diseases.
    CUMINGS JN
    Proc R Soc Med; 1954 Feb; 47(2):152-4. PubMed ID: 13134199
    [No Abstract]   [Full Text] [Related]  

  • 31. [Activator protein-1 mRNA expression, cell proliferation and collagen synthesis induced by tumor necrosis factor-alpha in cardiac fibroblasts from rats and the effect of Qiangxin Decoction].
    Shen Y; Yan SY
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):946-51. PubMed ID: 18782540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Wilson's disease or hepatolenticular degeneration].
    Podesta HA; Carcia Dadoni LR; Mazzei CM; Diez E; De Prado Isla LH; Macias A
    Prensa Med Argent; 1968 Mar; 55(1):32-7. PubMed ID: 5746721
    [No Abstract]   [Full Text] [Related]  

  • 33. [Aspects of chemical pathology in 2 cases of Wilson's disease].
    Alloro L; Pecorari T
    Riv Sper Freniatr Med Leg Alien Ment; 1968 Oct; 92(5):1381-401. PubMed ID: 5738558
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolism of copper in hepatolenticular degeneration.
    ZIMDAHL WT; HYMAN I; COOK ED
    Neurology; 1953 Aug; 3(8):569-76. PubMed ID: 13087576
    [No Abstract]   [Full Text] [Related]  

  • 35. [Efficacy of microencapsulated HepG2 cells transplantation in rats with hepatolenticular degeneration].
    Lin HL; Chen J; Huang LT; Chen YP
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Dec; 12(12):959-62. PubMed ID: 21172132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Copper metabolism after living related liver transplantation for Wilson's disease].
    Wang XH; Cheng F; Zhang F; Li XC; Li GQ
    Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):303. PubMed ID: 15161511
    [No Abstract]   [Full Text] [Related]  

  • 37. COPPER metabolism in hepatolenticular degeneration.
    J Am Med Assoc; 1955 Jun; 158(5):402-3. PubMed ID: 14367097
    [No Abstract]   [Full Text] [Related]  

  • 38. [Wilson's disease. I].
    Sánchez Rodríquez A; González Macias J; Diez Jarilla JL; Suquia Múgica B; de Portugal Alvarez J
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):68-73. PubMed ID: 6753060
    [No Abstract]   [Full Text] [Related]  

  • 39. [The content of copper in the tissues of patients with hepatolenticular degeneration].
    BAUMAN LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():1141-5. PubMed ID: 13687972
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of oxidative events and copper accumulatıon in oral tissues of patients wıth Wilson's disease: three case report.
    Ozturk M; Karacelebi E; Gungor K; Coskun S; Boysan E
    Int J Clin Exp Pathol; 2015; 8(4):3943-5. PubMed ID: 26097579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.